Fresenius Medical Care AG
FME: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| <B | LOCK|^<DJ | LOCK|KN>q#H& |
Fresenius Medical Care Earnings: Profits Keep Expanding on Transformation Initiatives
In the fourth quarter, global dialysis services and medical technology leader Fresenius Medical Care turned in revenue growth of 5% in constant currency, excluding divestitures, and adjusted operating income growth of 31%.
